Article info

Download PDFPDF
Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up

Authors

  • Pomme BM Poppelaars Amsterdam Rheumatology and immunology Centre, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Lilian H D van Tuyl Amsterdam Rheumatology and immunology Centre, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Maarten Boers Amsterdam Rheumatology and immunology Centre, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands Epidemiology & Biostatistics, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Maarten Boers, Epidemiology & Biostatistics, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam 1007 MB, Netherlands; eb{at}vumc.nl
View Full Text

Citation

Poppelaars PB, van Tuyl LHD, Boers M
Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up

Publication history

  • Received October 19, 2018
  • Revised January 28, 2019
  • Accepted January 30, 2019
  • First published February 26, 2019.
Online issue publication 
April 12, 2019

Article Versions